Glatopa

New Study Supports Hitting MS Fast and Hard

The question of how quickly to start a disease-modifying therapy (DMT) after a multiple sclerosis (MS) diagnosis is one that I frequently see when I browse online. It goes hand in hand with questions about which DMT is best to start with. There are many things to consider when…

Generic Form of Glatiramer Acetate Has Equivalent Gene Expression Profile as Teva’s Copaxone

In a recent study entitled ā€œEquivalent Gene Expression Profiles between Glatopaā„¢ and CopaxoneĀ®,ā€ authors determined potential differences in treatment responses by investigating the gene expression profile of two approved treatments for relapsing forms of multiple sclerosis ā€“ Copaxone and Glatopa. Both of these MS therapies are glatiramer…